Acquiring Company
INVO Bioscience
Acquired Company
NAYA Biosciences
SarasotaAventuraBiotechnologyHealthcareHealth CareMedicalDescription
INVO Bioscience is set to merge with NAYA Biosciences as part of a strategic turnaround in fertility technology. The merger follows a recent reverse stock split and a relisting on Nasdaq. INVO aims to strengthen its INVOcell device offering while reducing costs in assisted reproduction. This merger is expected to enhance INVO's market position in fertility treatments.
Who to call at INVO Bioscience, and when
When INVO Bioscience changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day INVO Bioscience raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at INVO Bioscience, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at INVO Bioscience. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment INVO Bioscience makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired NAYA Biosciences?
NAYA Biosciences was acquired by INVO Bioscience, based in Sarasota. The deal was reported on May 17, 2026. At INVO bioscience, we are democratizing fertility. INVO Bioscience is publicly traded (IVF) and operates in Biotechnology.
When did INVO Bioscience acquire NAYA Biosciences?
INVO Bioscience's acquisition of NAYA Biosciences was reported on May 17, 2026. INVO Bioscience is set to merge with NAYA Biosciences as part of a strategic turnaround in fertility technology. The merger follows a recent reverse stock split and a relisting on Nasdaq. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does NAYA Biosciences do?
NAYA Biosciences is building a group of companies leveraging the next generation of biotechnologies to increase patient access to life-transforming treatments in oncology, fertility, and regenerative medicine. It is privately held, and is based in Aventura.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.